Sagimet Biosciences (SGMT) Shares Outstanding (Entity) (2022 - 2026)
Sagimet Biosciences' Shares Outstanding (Entity) came in at 53.11 million for Q2 2026, up 65.0% from 32.2 million a year earlier and up 63.1% from the prior quarter.
Powered by 
Analysis
Sagimet Biosciences (SGMT) Shares Outstanding (Entity) (2022 - 2026) Analysis & Trends
For FY2025, Sagimet Biosciences' Shares Outstanding (Entity) was 32.35 million, up 3.2% from FY2024.
- Shares Outstanding (Entity) carries a three-year compound annual growth rate of 459.1% (FY2022 to FY2025).
- Going back by year, Shares Outstanding (Entity) was 31.35 million in FY2024 (+36.9%), 22.9 million in FY2023 and 185,084 in FY2022.
- The Q2 2026 figure represents the highest quarterly Shares Outstanding (Entity) in data going back to Q2 2022.
- Year-over-year, Shares Outstanding (Entity) has increased for eight consecutive quarters, with growth averaging 19.9% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.9% (Q2 2025) to 65.0% (Q2 2026).
- Business Quant data shows SGMT's Shares Outstanding (Entity) at 32.56 million (Q1 2026), 32.35 million (Q4 2025) and 32.46 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Sagimet Biosciences | 524.77 Mn | 524.77 Mn | - | 53.11 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 53.11 Mn |
| Mar 31, 2026 | 32.56 Mn |
| Dec 31, 2025 | 32.35 Mn |
| Sep 30, 2025 | 32.46 Mn |
| Jun 30, 2025 | 32.20 Mn |
| Mar 31, 2025 | 32.20 Mn |
| Dec 31, 2024 | 31.35 Mn |
| Sep 30, 2024 | 32.14 Mn |
| Jun 30, 2024 | 31.91 Mn |
| Mar 31, 2024 | 29.04 Mn |
| Dec 31, 2023 | 22.90 Mn |
| Sep 30, 2023 | 22.90 Mn |
| Jun 30, 2023 | 210,315.00 |
| Mar 31, 2023 | 185,084.00 |
| Dec 31, 2022 | 185,084.00 |
| Sep 30, 2022 | 185,084.00 |
| Jun 30, 2022 | 185,084.00 |
API Access
Sagimet Biosciences Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SGMT&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "SGMT", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=SGMT&period=max&api_key=YOUR_API_KEY");
const data = await res.json();